logo

Concert Pharmaceuticals, Inc. (CNCE)



Trade CNCE now with
  Date
  Headline
4/25/2018 7:13:14 AM Concert Pharma Completes Enrollment In Phase 2a Trial Of CTP-543 In Alopecia Areata
3/1/2018 7:21:53 AM Concert Pharma FY17 Net Income $95.6 Mln Or $4.20/shr Vs. Net Loss $50.7 Mln Or $2.28/shr Last Year
1/12/2018 7:05:56 AM FDA Grants Fast Track Designation To Concert Pharmaceuticals’ CTP-543 For Treatment Of Alopecia Areata
1/12/2018 7:05:28 AM Concert Announces Patent Trial And Appeal Board Did Not Institute PGR Proceeding
12/22/2017 1:20:23 AM In The Spotlight: Concert Pharma
12/18/2017 7:06:15 AM Concert Pharma Names Marc Becker CFO, Effective Jan. 4
11/9/2017 7:25:26 AM Concert Pharma Q3 Net Income $128.1 Mln Or $5.61/Shr Vs Loss Of $11.4 Mln Or $0.51/Shr Last Year
11/6/2017 7:13:40 AM Concert Pharma Completes Enrollment In First Cohort Of CTP-543 Phase 2a Trial
8/8/2017 7:05:01 AM Concert Pharma Q2 Net Loss $13.0 Mln Or $0.58/Shr Vs Loss Of $13.4 Mln Or $0.60/Shr Last Year
7/25/2017 4:07:48 PM Vertex And Concert Pharmaceuticals Announce Completion Of Asset Purchase Agreement
7/10/2017 7:32:14 AM FDA Lifts Clinical Hold On Concert Pharmaceuticals Clinical Trial With CTP-543